These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18987785)
1. Oxidative modification of LDL: its pathological role in atherosclerosis. Itabe H Clin Rev Allergy Immunol; 2009 Aug; 37(1):4-11. PubMed ID: 18987785 [TBL] [Abstract][Full Text] [Related]
2. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody]. Itabe H Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156 [TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Itabe H Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163 [TBL] [Abstract][Full Text] [Related]
4. Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells. Itabe H; Takano T J Atheroscler Thromb; 2000; 7(3):123-31. PubMed ID: 11480452 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Radulescu L; Stancu C; Antohe F Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494 [TBL] [Abstract][Full Text] [Related]
6. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Boyd HC; Gown AM; Wolfbauer G; Chait A Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796 [TBL] [Abstract][Full Text] [Related]
7. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Tsimikas S; Palinski W; Witztum JL Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies. Hulthe J Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde. Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571 [TBL] [Abstract][Full Text] [Related]
10. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease. Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649 [TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Nishi K; Itabe H; Uno M; Kitazato KT; Horiguchi H; Shinno K; Nagahiro S Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1649-54. PubMed ID: 12377744 [TBL] [Abstract][Full Text] [Related]
13. Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis. Cerne D; Jürgens G; Ledinski G; Kager G; Greilberger J; Lukac-Bajalo J Clin Chem Lab Med; 2002 Jan; 40(1):15-20. PubMed ID: 11916265 [TBL] [Abstract][Full Text] [Related]
14. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Shaw PX Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487 [TBL] [Abstract][Full Text] [Related]
16. The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions. Itabe H; Kato R; Sawada N; Obama T; Yamamoto M Curr Med Chem; 2019; 26(9):1576-1593. PubMed ID: 29521196 [TBL] [Abstract][Full Text] [Related]
17. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Matsuura E; Kobayashi K; Hurley BL; Lopez LR Lupus; 2006; 15(7):478-83. PubMed ID: 16898186 [TBL] [Abstract][Full Text] [Related]
18. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699 [TBL] [Abstract][Full Text] [Related]
19. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients. Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326 [TBL] [Abstract][Full Text] [Related]